Surgical metastasectomy for renal cell carcinoma: which patients are the real candidates for surgery?
作者信息
Kato Satoshi, Demura Satoru, Murakami Hideki, Tsuchiya Hiroyuki
机构信息
Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
Department of Orthopaedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S273. doi: 10.21037/atm.2019.11.139.
Abstract
摘要
相似文献
1
Surgical metastasectomy for renal cell carcinoma: which patients are the real candidates for surgery?肾细胞癌的手术性转移灶切除术：哪些患者是真正的手术候选者？
Ann Transl Med. 2019 Dec;7(Suppl 8):S273. doi: 10.21037/atm.2019.11.139.
2
Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.转移性肾细胞癌患者行完全转移灶切除术的疗效：系统评价和荟萃分析。
J Urol. 2017 Jan;197(1):44-49. doi: 10.1016/j.juro.2016.07.079. Epub 2016 Jul 26.
3
The role of metastasectomy in advanced renal cell carcinoma.转移性肾细胞癌切除术的作用。
Expert Rev Anticancer Ther. 2019 Jul;19(7):603-611. doi: 10.1080/14737140.2019.1625772. Epub 2019 Jun 8.
4
Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era.细胞因子时代后肾细胞癌的完全外科转移切除术。
J Urol. 2020 Feb;203(2):275-282. doi: 10.1097/JU.0000000000000488. Epub 2019 Aug 8.
5
Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.肾细胞癌的外科转移切除术：系统评价。
Eur Urol Oncol. 2019 Mar;2(2):141-149. doi: 10.1016/j.euo.2018.08.028. Epub 2018 Sep 24.
6
Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questions.肾细胞癌转移灶切除术后的全身治疗：借鉴其他临床领域的见解来解答未解决的问题。
Urol Oncol. 2018 Jan;36(1):17-22. doi: 10.1016/j.urolonc.2017.06.005. Epub 2017 Jul 20.
7
Metastasectomy for metastatic renal cell carcinoma in the era of modern systemic treatment: C-reactive protein is an independent predictor of overall survival.现代全身治疗时代转移性肾细胞癌的转移灶切除术：C反应蛋白是总生存的独立预测因素。
Int J Urol. 2016 Nov;23(11):916-921. doi: 10.1111/iju.13171. Epub 2016 Aug 12.
8
Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.肾细胞癌转移灶的手术治疗：靶向治疗时代的治疗结果及鲁汶-乌迪内预后分组的初步评估
Scand J Urol. 2018 Oct-Dec;52(5-6):419-426. doi: 10.1080/21681805.2018.1553893. Epub 2019 Jan 20.
9
Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).肾细胞癌（RCC）非典型转移的外科治疗。
BJU Int. 2012 Dec;110(11 Pt B):E559-63. doi: 10.1111/j.1464-410X.2012.11271.x. Epub 2012 May 28.
10
The Evolving Role of Metastasectomy for Patients with Metastatic Renal Cell Carcinoma.转移性肾细胞癌患者转移灶切除术的演变角色。
Urol Clin North Am. 2020 Aug;47(3):379-388. doi: 10.1016/j.ucl.2020.04.012. Epub 2020 Jun 10.
引用本文的文献
1
Navigating advanced renal cell carcinoma in the era of artificial intelligence.在人工智能时代应对晚期肾细胞癌
Cancer Imaging. 2025 Feb 18;25(1):16. doi: 10.1186/s40644-025-00835-7.
2
Adjuvant therapy in renal cell carcinoma (RCC): progress, at last.肾细胞癌的辅助治疗：终于取得进展。
Transl Cancer Res. 2024 Nov 30;13(11):6448-6462. doi: 10.21037/tcr-23-2247. Epub 2024 Aug 12.
3
Renal cell carcinoma (RCC) spreading to the larynx: an unusual condition.肾细胞癌（RCC）转移至喉部：一种不常见的情况。
BMJ Case Rep. 2024 Jan 24;17(1):e255459. doi: 10.1136/bcr-2023-255459.
4
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?寡转移肾细胞癌：立体定向体部放射治疗，何时、何地以及如何治疗？
Clin Transl Oncol. 2021 Aug;23(8):1717-1726. doi: 10.1007/s12094-021-02574-0. Epub 2021 Mar 9.
本文引用的文献
1
Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era.细胞因子时代后肾细胞癌的完全外科转移切除术。
J Urol. 2020 Feb;203(2):275-282. doi: 10.1097/JU.0000000000000488. Epub 2019 Aug 8.
2
Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis.转移性肾细胞癌患者仅接受靶向治疗时转移灶切除术的生存和并发症发生率：一项基于人群的综合分析。
Anticancer Res. 2019 Aug;39(8):4357-4361. doi: 10.21873/anticanres.13604.
3
Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.肾细胞癌的外科转移切除术：系统评价。
Eur Urol Oncol. 2019 Mar;2(2):141-149. doi: 10.1016/j.euo.2018.08.028. Epub 2018 Sep 24.
4
Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.2005-2014 年在瑞典两家中心接受立体定向放疗或手术转移灶切除术治疗的寡转移肾细胞癌患者的总生存情况。
Radiother Oncol. 2018 Jun;127(3):501-506. doi: 10.1016/j.radonc.2018.04.028. Epub 2018 May 10.
5
Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy.透明细胞肾细胞癌的分子亚型对完全转移手术后的预后有预测价值。
Eur Urol. 2018 Oct;74(4):474-480. doi: 10.1016/j.eururo.2018.01.042. Epub 2018 Feb 17.
6
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.肾癌，2017 年第 2 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Jun;15(6):804-834. doi: 10.6004/jnccn.2017.0100.
7
Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment.肾细胞癌转移切除术的并发症：基于人群的评估。
Eur Urol. 2017 Aug;72(2):171-174. doi: 10.1016/j.eururo.2017.03.005. Epub 2017 Mar 27.
8
Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.转移性肾细胞癌患者行完全转移灶切除术的疗效：系统评价和荟萃分析。
J Urol. 2017 Jan;197(1):44-49. doi: 10.1016/j.juro.2016.07.079. Epub 2016 Jul 26.
9
Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.靶向治疗时代肾细胞癌骨转移患者的生存及预后因素：单机构分析
Urol Oncol. 2016 Oct;34(10):433.e1-8. doi: 10.1016/j.urolonc.2016.05.017. Epub 2016 Jun 16.
10
Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.肾细胞癌脊柱转移瘤切除术：一项单中心16年经验，至少随访3年。
J Surg Oncol. 2016 Apr;113(5):587-92. doi: 10.1002/jso.24186. Epub 2016 Feb 5.
Zotero 插件